BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10588545)

  • 1. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Zupančič D; Ovčak Z; Vidmar G; Romih R
    Virchows Arch; 2011 May; 458(5):603-13. PubMed ID: 21301865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
    Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
    Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
    J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of four uroplakins in urothelial preneoplastic lesions.
    Zupančič D; Zakrajšek M; Zhou G; Romih R
    Histochem Cell Biol; 2011 Oct; 136(4):491-500. PubMed ID: 21853341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
    Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
    Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uroplakins and cytokeratins in the regenerating rat urothelium after sodium saccharin treatment.
    Romih R; Jezernik K; Masera A
    Histochem Cell Biol; 1998 Mar; 109(3):263-9. PubMed ID: 9541475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
    Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uroplakin gene expression by normal and neoplastic human urothelium.
    Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
    Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
    Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
    Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin.
    Oliveira PA; Palmeira C; Colaço A; de la Cruz LF; Lopes C
    Anticancer Res; 2006; 26(4B):2995-3004. PubMed ID: 16886626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
    Dunois-Lardé C; Levrel O; Brams A; Thiery JP; Radvanyi F
    Mol Carcinog; 2005 Mar; 42(3):142-9. PubMed ID: 15690367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
    J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
    Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okajima E; Denda A; Ozono S; Takahama M; Akai H; Sasaki Y; Kitayama W; Wakabayashi K; Konishi Y
    Cancer Res; 1998 Jul; 58(14):3028-31. PubMed ID: 9679967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low susceptibility of Long-Evans Cinnamon rats to N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis and inhibitory effect of urinary copper.
    Chone Y; Kinouchi T; Yamada T; Suzuki Y; Kitaura K; Jiao Z; Minami T; Bando Y; Uehara H; Mochizuki M; Ohnishi Y; Izumi K
    Jpn J Cancer Res; 2000 Jan; 91(1):16-24. PubMed ID: 10744040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.